By 2023, the global drug delivery generation industry is expected to be worth $43. 9 billion. The expansion of the overall market is expected to be driven by the increasing use of complex technologies to successfully deliver the drugs at the target site. Between 2023 and 2033, global demand for drug delivery technologies is projected to grow at a CAGR of 12. 6%, reaching more than $143. 5 billion.
Solid Oral Dose Manufacturers in North America Have Been Able to Achieve Significant Bioavailability
Click here to claim your report with images.
The IMF report estimates that North America will remain the largest market for the generation of controlled-release oral medicines, with estimated sales of nearly $20 billion through the end of 2027. Being the preferred direction of drug administration through physicians, the need for a generation of oral administration of controlled-release drugs has noticed an increase by end-users in North America. In addition, recent advances in drug delivery have enabled counterfeit brands of oral doses in North America to have significant bioavailability through the adoption of new drug delivery platforms. This is expected to drive the demand for controlled-release drug oral delivery technologies in the region.
New Chemical Entities Resulting from High-Throughput Screening to Drive Market Growth in Western Europe
Western Europe will witness the fastest expansion in the global market for controlled-release oral drug delivery technologies. This expansion is basically attributed to a multitude of new chemical entities resulting from high-throughput detection, which have low solubility and bioavailability. brands in this region to invest in drug delivery strategies that deliver better clinical outcomes. Due to load sensitivity in Western European countries, bioavailability-enhancing technologies will continue to be the preferred drug delivery system. These points are expected to drive the expansion of the market. in this region.
However, most pharmaceutical corporations in Western Europe have a complex chain that is underutilized or inefficient. The complexity of the chain is attributed to low flexibility and low profitability. In addition, the shortening of the effective life of patents, as well as patent infringements, are a major challenge for the falsified oral dosing bureaucracy in this region. These points are estimated to hinder the expansion of the market in Western Europe.
The controlled-dissolve formula will continue to be sought after among the drug delivery technologies on the market.
In terms of drug delivery technology, the solution-controlled-release formula will continue to be sought after in the market, followed by the diffusion-controlled-release formula. Most of the generic formulations available come in pill form and adhere to a controlled regimen. Dissolution release mechanism. Revenue from sales of solution-controlled-release formulas will exceed $10 billion in 2017. Demand for hydrodynamically balanced drug delivery formulations will remain sluggish in the market.
The robust dosing bureaucracy of the controlled-release oral drug generation is expected to remain dominant in the market, developing at a high single-digit CAGR through 2027. Sales in the semi-solid/liquid/suspension dosage forms segment will register a relatively low pace. lower CAGR than counterfeit dosing bureaucracy. dosing bureaucracy on the market until 2027.
Key market players known in the IMF report include
Market taxonomy
By region
By Medication Delivery System
By Dosage Form
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award winner, and member of the New York Chamber of Commerce) offers an in-depth look at the driving points driving demands in the market. FMI is the world’s leading provider of market services. Intelligence, consulting, advisory and occasion facilities for the packaging, food and beverage, customer technology, healthcare, commercial and chemical markets. With an extensive team of more than 5,000 analysts worldwide, FMI provides global, regional and local expertise on industry spaces and trends. in more than 110 countries.
Contact us:
Nandini Singh Sawlani
The Associate Vice President of Future Market Insights is deeply committed to uncovering actionable insights for customers and food and beverage stakeholders. He brings a combination of analytics, industry trends, and customer habits to put insights into perspective.
What you do with knowledge becomes a pleasure to read. She is a reviewer and contributor to publications such as Process Industry Informer and Spinal Surgery News as she understands the pulse of the market and the conversion of customer preferences.
He likes to invite experts to a roundtable to assess the effect of a trend on an industry. Read their discussion on the effect of AI on packaging.